Patient Involvement Blog

Latest Tweets

News Archives

News Category: Vaccines

BRC researcher honoured for Africa radio project

A researcher supported by the NIHR Oxford Biomedical Researcher has been recognised by the University of Oxford for work to communicate with children in Africa about the Ebola outbreak. Dr Matthew Snape was one of 12 winners in the inaugural Vice-Chancellor’s Awards for Public Engagement with Research. Dr Snape, of the University’s Oxford Vaccine Group, … Read more

Data debate video and podcast now online

A video of an hour-long debate on issues around mass sharing of patient data to support research and improve patient care can now be viewed online. “Good to share? Data, research, privacy and the NHS” was held as part of the NIHR Oxford Biomedical Research Centre’s Public Open Day – Celebrating Biomedical Research on April … Read more

Prostate cancer vaccine trial seeks volunteers

Oxford University scientists have started a clinical trial to test a new vaccine against prostate cancer and are looking for volunteers to take part. The first four participants have already received this experimental vaccine at the Churchill Hospital in Oxford, and the second trial site has just been opened at the Royal Hallamshire Hospital in … Read more

Volunteers sought for childhood infection vaccine study

Oxford University researchers are looking for healthy adults to take part in the initial BRC-supported trial of a potential new vaccine against a virus considered to be a crucial missing element in the childhood vaccination programme. Respiratory syncytial virus (RSV) kills around 200,000 people worldwide each year. Both the elderly and infants are especially vulnerable … Read more

First trial for childhood illness vaccine

Oxford University researchers supported by the NIHR Oxford Biomedical Research Centre have successfully completed the first human trial of a vaccine for a common virus that is particularly dangerous to infants. After fifty years of failed attempts around the world, a vaccine for respiratory syncytial virus (RSV), a major cause of respiratory disease, may now … Read more

Oxford Ebola vaccine study moves to next phase

Oxford University doctors and scientists are performing the second phase of clinical studies of an experimental Ebola vaccine regimen, with part of the study supported by the NIHR Oxford Biomedical Research Centre. The study is part of the EBOVAC2 project, a collaborative programme involving the University of Oxford, French Institute of Health and Medical Research … Read more

BRC supports Oxford Ebola summit

The NIHR Oxford Biomedical Research Centre is among organisations supporting a conference in the city next month about the global response to Ebola. Researchers, Government leaders and industry professionals who led the worldwide fight against Ebola are to come together in Oxford for the first time since the disease was largely controlled. Speakers, including the … Read more

World-first TB vaccination trials enter next stage

THE first ever trials of an aerosol vaccination for tuberculosis in Oxford have shown promising results and volunteers are now being sought for further studies. University of Oxford researchers working at the Churchill Hospital found superior immune responses in the lungs from the trial of a vaccine given via an aerosol which creates a mist … Read more

Scientists showcase search for a meningitis vaccine

THE FIGHT to tackle meningitis was highlighted at a Vaccines and Deadly Diseases Day. The all-day event for young people on Friday at Oxford University Museum of Natural History was part of this year’s Oxfordshire Science Festival.  Among those taking part were Oxford University scientists who are trying to find a new meningitis vaccine. Click … Read more

Oxford leads search for longer lasting flu vaccine

Oxford leads search for longer lasting flu vaccine   Researchers at Oxford University are leading the search for better flu vaccines.   Thousands of people in Oxfordshire have already had the jab to protect them against this year’s strain of flu – but they will need to do it again next year to stay protected. … Read more

How has the pneumococcus bacteria evolved after the introduction of a childhood vaccine?

Researchers from the University of Oxford and the US Centers for Disease Control and Prevention (CDC) used the latest DNA sequencing techniques to investigate how pneumococcus bacteria evolved after the introduction of a childhood vaccine in 2000 in the USA. Streptococcus pneumoniae infections are thought to kill around one million young children each year. Although … Read more

First trial of a new hepatitis C vaccine shows promise

A new vaccine against the chronic liver disease hepatitis C has shown promising results in a first clinical trial in humans, Oxford University researchers report. The vaccine, based on a modified cold virus, generated immune responses similar to those seen in the minority of people who are naturally able to clear any infection with the … Read more

Final child vaccinated in clinical trial of new TB vaccine

The vaccination of the final child marks a significant milestone in the development of the MVA85A/AERAS-485 vaccine candidate, the most advanced of any of the new generation of preventative TB vaccines currently being investigated. Tuberculosis kills 1.8 million people per year, and more than 2 billion people worldwide are infected with TB – approximately one … Read more

Universal flu vaccine developed in Oxford

Scientists at Oxford University have successfully tested a universal flu vaccine that could work against all known strains of the illness, taking a significant step in the fight against a disease that affects billions of people each year. The treatment – using a new technique and tested for the first time on humans infected with … Read more

Swine flu clinical trial results published

Last autumn the Oxford Vaccine Group was the lead site on a novel influenza H1N1 (‘Swine Flu’) vaccine study that enrolled over 900 children in 5 weeks. This rapid recruitment enabled us to provide data to the Department of Health in time to directly inform the national ‘Swine Flu’ immunisation policy, and was only possible … Read more

New method makes vaccines stable at tropical temperatures

A simple and cheap way of making vaccines stable – even at tropical temperatures – has been developed by scientists at Oxford University and Nova Bio-Pharma Technologies. The British technology has the potential to revolutionise vaccination efforts, particularly in the developing world where infectious diseases kill millions of people every year, by removing the need … Read more

Viral Hepatitis affects 1 in 12 people around the world – find out more

You are invited to attend a public lecture by leading experts Drs Jane Collier, Ellie Barnes and Prof Paul Klenerman.  Would you like to learn about current treatments of hepatitis C infection, exciting drug developments that will reach the clinic soon and new vaccines being developed in Oxford. Would you like to participate in studies … Read more

Launch of new Oxford Vaccinology Programme

In November, The Jenner Institute will be launching the new Oxford Vaccinology Programme in collaboration with the University’s Department for Continuing Education.This academic year, the Programme will offer a five-day course in ‘Human and Veterinary Vaccinology’, followed by two shorter courses in March 2010, in ‘Clinical Vaccine Development’ and ‘Vaccine Biomanufacturing’. The courses are aimed … Read more

Swine Flu Vaccine Trial

The Oxford Vaccine Group, part of the University of Oxford, would like to invite you and your child to take part in a study of 2 new vaccines aimed at providing protection against Swine Flu. For more information please visit: http://www.oxfordtimes.co.uk/news/4644569.Swine_flu_vaccine_trial/